Latham & Watkins represented Spectrum Pharmaceuticals in the deal.Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI), a biopharmaceutical company focused on novel and targeted oncology therapies, has entered into a…
Spectrum Pharmaceuticals’ $65 Million Debt Financing Agreement With SLR Capital Partners
